Trial Profile
A Phase I, Single-Centre, Randomised, Open-Label, Five-Way Cross-Over Formulation- and Food-Effect Study in Healthy Volunteers to Assess the Pharmacokinetics of AZD1386 After Single Doses of Two Oral Solid Formulations and an Oral Solution
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2010
Price :
$35
*
At a glance
- Drugs AZD 1386 (Primary)
- Indications Gastro-oesophageal reflux; Pain
- Focus Pharmacokinetics
- 09 Dec 2010 Actual end date changed from Sep 2008 to Aug 2008 as reported by ClinicalTrials.gov.
- 24 Sep 2008 Actual start date changed from Aug 2008 to Sep 2008 as reported by Clinicaltrials.gov
- 24 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov